The JV is in line with the increasing participation of Japanese medical institutions in the TriNetX network. Credit: aslysun/Shutterstock.

TriNetX has collaborated with Fujitsu to establish TriNetX Japan KK, a joint venture (JV) aimed at transforming the utilisation of anonymised electronic health record (EHR) data from Japanese individuals to accelerate healthcare research and clinical trials.

The collaboration is set to integrate the country more fully into the worldwide data-driven healthcare landscape.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The new entity will leverage TriNetX’s LIVE platform, which encompasses a network of more than 200 million records of patients, with Fujitsu’s cloud-based platform.

TriNetX LIVE is the largest federated network of real-world data and harmonises diverse datasets including EHRs, lab outcomes and data from the tumour registries into a unified data model.

This facilitates on-demand cohort creation and analysis for researchers and life sciences companies, enabling them to conduct analytics and access large-scale EHR datasets securely.

The JV is in line with the increasing participation of Japanese medical institutions in the TriNetX network.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

These institutions are engaging in new studies leveraging TriNetX’s technology and data and pharmaceutical companies are extending clinical trial opportunities to them.

TriNetX Japan KK will be led by Shogo Wakabayashi, the country manager for TriNetX in Japan.

TriNetX chief operating officer Steve Kundrot and the company’s mergers and acquisitions and business development vice-president Elizabeth Schwert are set to join the board of directors of the JV.

Fujitsu healthy living head Tatsuki Araki stated: “Fujitsu is proud to collaborate with TriNetX to advance healthcare and life sciences innovation in Japan. Together with TriNetX, we will create an environment where Japanese medical data, previously underutilised, can be efficiently leveraged for clinical research.

“As part of our business model “Fujitsu Uvance,” which is based on addressing social issues, Fujitsu aims to eliminate drug loss in Japan and achieve a society where everyone can choose the treatment that best suits them by creating an ecosystem leveraging medical data.”